Citigroup’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $110K | Sell |
|
|||||
|
2025
Q2 | $301K | Sell |
|
|||||
|
2025
Q1 | $185K | Sell |
|
|||||
|
2024
Q4 | $438K | Buy |
|
|||||
|
2024
Q3 | $267K | Buy |
|
|||||
|
2024
Q2 | $98.4K | Sell |
|
|||||
|
2024
Q1 | $732K | Sell |
|
|||||
|
2023
Q4 | $550K | Buy |
|
|||||
|
2023
Q3 | $888K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $1K | Sell |
|
|||||
|
2022
Q2 | $4K | Sell |
|
|||||
|
2022
Q1 | $67K | Sell |
|
|||||
|
2021
Q4 | $124K | Buy |
|
|||||
|
2021
Q3 | $62K | Buy |
|
|||||
|
2021
Q2 | $29K | Buy |
|
|||||
|
2021
Q1 | $12K | Sell |
|
|||||
|
2020
Q4 | $43K | Buy |
|